Zyrop 5000IU injection contains active components such as Recombinant human erythropoietin alfa/epoetin alfa. It is a medication that belongs to a class of drugs called erythropoiesis-stimulating agents (ESAs). This medication treats anemia caused by chronic kidney disease (CKD), cancer chemotherapy, or HIV infection treatment with zidovudine. It also reduces the need for red blood cell transfusions in patients at high risk for blood loss due to planned surgery or other procedures. Zyrop 5000IU injection should not be used in patients with hypersensitivity to it or any of its components, uncontrolled hypertension, active thrombotic microangiopathy (TMA), pure red cell aplasia (PRCA), uncontrolled seizures, pregnancy, or lactation. It should also be used cautiously in patients with a history of blood clots, heart disease, stroke, kidney disease, liver disease, thalassemia, sickle cell anemia, myelodysplastic syndrome, leukemia, or cancer. It should only be used in children under 18 if the benefits outweigh the risks. Older adults taking this medication should be closely monitored for side effects. Before starting this medication, it is important to talk to your doctor about the risks and benefits of Zyrop 5000IU injection.

Bleocel 15mg Injection consists of the active ingredient Bleomycin. It belongs to a group of drugs known as antineoplastic antibiotics. It is commonly used in cancer treatment to slow or stop the growth of cancer cells. It is used to treat lymph node cancers (Hodgkin’s and non-Hodgkin’s lymphoma), head and neck cancer, and cancer in external genitalia. It either be used alone or with radio therapy and chemotherapy treatment. This injection is also beneficial to prevent and treat the fluid accumulation in the lungs that occurs due to cancer. It works by interfering with the production of DNA and RNA in cancer cells. It can cause breaks in the DNA strands and prevent cancer cells from dividing and growing. Bleocel 15mg injection can have side effects, including lung problems, skin reactions, fever, and nausea. In some cases it can also affect kidneys, liver, and heart. Patients receiving it, need to be closely monitored for these side effects. It is typically administered through injection or infusion, either alone or in combination with other chemotherapy drugs. The dosage and frequency of treatment depend on several factors, including the type and stage of cancer, the patient's age and overall health, and the specific treatment plan developed by the oncologist.

Zynesp 100mcg injection contains the active ingredient Darbepoetin Alfa. It is an antineoplastic drug that belongs to the class of medications called hematopoietic growth factors. It is used to treat anemia (lower than normal RBC) in people with chronic kidney disease. It is also indicated to treat anemia caused by chemotherapy in people with certain types of cancer. The symptoms of anemia are fatigue, weakness, and shortness of breath. Do not take Zynesp 100mcg injection if you are allergic to Darbepoetin alfa or any other ingredients and have uncontrolled blood pressure. Inform your physician if you have high blood pressure, anemia, a history of seizures, epilepsy, liver disease, or allergy to latex or hepatitis C. Inform your physician if you are pregnant or breastfeeding. If you have severe headache, dizziness, drowsiness, confusion, problems with your eyesight, nausea, vomiting, or seizures after taking Zynesp 100mcg injection, inform your physician immediately and seek medical advice. This medicine's most common side effects are hypertension, shortness of breath, swelling in the legs, and cough.

Biotrexate 15mg Injection contains the active substance Methotrexate. It is an anti-metabolite and immunosuppressant drug. It treats certain types of cancer, such as acute lymphocytic leukemia (ALL), meningeal leukemia, non-hodgkin’s lymphoma, osteosarcoma, cutaneous T-cell lymphoma, breast cancer, and head and neck cancer in adults. It is also used to treat severe psoriasis in adults (a skin disease in which red, scaly patches form on some body areas). It is also indicated to treat rheumatoid arthritis in adults. Do not use Biotrexate 15mg Injection if you are allergic to methotrexate or any of the other ingredients of this medicine. Do not take this medicine if you have kidney or liver problems, blood disorders, weakened immune system, pregnant, or breastfeeding. Inform your physician immediately if you experience any symptoms of spitting and coughing up blood, general muscle weakness, vision disturbance, changes in thinking, memory, and orientation problems. This medicine may impair fertility. Avoid getting pregnant during the treatment and for six months after the last dose.

Bioposide 100mg injection is an anticancer drug with the ingredient Etoposide. It belongs to the medication class known as cytostatic. It is used to treat certain types of cancers such as testicular cancer, small-cell lung cancer, acute myeloid leukemia (blood cancer), tumor in the lymphatic system (Hodgkin’s lymphoma, non-Hodgkin’s lymphoma), and ovarian cancer in adults. Talk to your doctor if you had or currently having radiotherapy or chemotherapy. Report to your doctor if you have any infections or low levels of protein (albumin) in your blood. Bioposide 100mg Injection should not be taken if you have recently been vaccinated with yellow fever or any live vaccines. Before starting treatment with this medicine, it is very important to tell your physician if you currently or previously had any medical conditions of kidney problems or liver disorders. Both women and men should use effective birth control during the treatment and at least 6 months after the last dose. In men, it is recommended not to father a child during and up to 6 months after the treatment. So it is advised to get suggestions about fertility concerns from your doctor. Administration of Bioposide 100mg injection may cause a reduction in the level of blood cells and increase the risk of developing infections. So, your doctor may perform blood tests regularly to monitor your kidney and liver function. It is unknown whether it is safe to use on a child.

Erypro safe 4000IU injection contains active components such as Recombinant human erythropoietin alfa/epoetin alfa. It is a medication that belongs to a class of drugs called erythropoiesis-stimulating agents (ESAs). This medication treats anemia caused by chronic kidney disease (CKD), cancer chemotherapy, or HIV infection treatment with zidovudine. It also reduces the need for red blood cell transfusions in patients at high risk for blood loss due to planned surgery or other procedures. Erypro safe 4000IU injection should not be used in patients with hypersensitivity to it or any of its components, uncontrolled hypertension, active thrombotic microangiopathy (TMA), pure red cell aplasia (PRCA), uncontrolled seizures, pregnancy, or lactation. It should also be used cautiously in patients with a history of blood clots, heart disease, stroke, kidney disease, liver disease, thalassemia, sickle cell anemia, myelodysplastic syndrome, leukemia, or cancer. It should only be used in children under 18 if the benefits outweigh the risks. Older adults taking this medication should be closely monitored for side effects. Before starting this medication, it is important to talk to your doctor about the risks and benefits of Erypro safe 4000IU injection.

Armotraz Tablet is used alone or with other treatments, such as surgery or radiation, to treat early breast cancer in postmenopausal women. It can also be used as the first line treatment of advanced breast cancer that has spread within the breast or to other areas of the body. Armotraz Tablet belong to a class of drug called aromatase inhibitors, which decreases the amount of estrogen in the body. It should be taken with or without food, but take it at the same time every day to get the most benefit. It should be taken as your doctor's advice. The dose and how often you take it depends on what you are taking it for. Your doctor will decide how much you need to improve your symptoms. Swallow the tablets whole with a drink of water. You should take this medicine for as long as it is prescribed for you. The most common side effects of the medicine include hot flushes, nausea, rashes, joint pain, osteoporosis, and weakness. If these bother you or appear serious, let your doctor know. There may be ways of reducing or preventing them. Before taking this medicine, tell your doctor if you are not gone through menopause and still having menstrual periods, or you have a problem with the liver or kidney. Your doctor should also know about all other medicines you are taking as many of these may make this medicine less effective or change the way it works. Tell your doctor if you are pregnant or breastfeeding. Your doctor may perform some blood tests to check for vitamin D level or bone density.

About I-Dox 20Mg/10Ml Inj I-Dox 20Mg/10Ml Inj is an anti-cancer medicine used in the treatment of cancer. Cancer is a disease where the cells grow abnormally and divide uncontrollably. I-Dox 20Mg/10Ml Inj is primarily used as adjuvant chemotherapy in women with axillary lymph nodes with involvement resection of breast cancer (abnormal growth in the cells of the breast). It is also used to treat neuroblastoma (cancer that starts in nerve cells and primarily affects children) and Wilms' tumor (a form of kidney cancer that affects children). I-Dox 20Mg/10Ml Inj contains Doxorubicin, which belongs to the class of anthracycline topoisomerase inhibitors. It inhibits the topoisomerase II enzyme by intercalating the DNA base pairs. This causes double helix DNA to be uncoiled, destroying DNA and RNA synthesis. I-Dox 20Mg/10Ml Inj may cause certain side effects such as nausea, headache, abdominal pain, loss of appetite, vomiting, dizziness, mouth sores, tiredness, back pain, red discoloration of urine, diarrhea, and pain at the site of injection. Most of these side effects do not require medical attention and gradually resolve over time. However, if the side effects persist, please consult your doctor. A trained healthcare doctor will administer I-Dox 20Mg/10Ml Inj. So, do not self-administer. Your doctor will decide the dose of the medicine based on your health condition. I-Dox 20Mg/10Ml Inj should be avoided if you are allergic to it or any other components of this medicine. It is contraindicated in patients having severe myocardial insufficiency, a recent history of myocardial infarction (MI), severe persistent drug-induced myelosuppression, and severe liver disease. Hence, if you have any such conditions, inform your doctor. Inform your doctor if you have any cardiovascular conditions, liver/kidney disease, or taking any CYP3A4 or CYP2D6 inducers medication, as it can cause adverse effects. I-Dox 20Mg/10Ml Inj is known to cause embryo-fetal toxicity. Hence, if you are pregnant or breastfeeding, inform your doctor beforehand. Uses of I-Dox 20Mg/10Ml Inj Treatment of Breast Cancer Directions for Use A trained healthcare professional will administer I-Dox 20Mg/10Ml Inj. Hence, do not self-administer. Medicinal Benefits I-Dox 20Mg/10Ml Inj contains Doxorubicin, which belongs to the class of anthracycline topoisomerase inhibitors. It inhibits the topoisomerase II enzyme by intercalating the DNA base pairs. This causes double helix DNA to be uncoiled, thereby destroying the DNA and RNA synthesis. I-Dox 20Mg/10Ml Inj is also used in the treatment of acute lymphoblastic leukaemia, acute myeloblastic leukaemia, Hodgkin lymphoma, Non-Hodgkin lymphoma, metastatic breast cancer, metastatic Wilms’ tumour, metastatic neuroblastoma, metastatic soft tissue sarcoma, metastatic bone sarcomas, metastatic ovarian carcinoma, metastatic transitional cell bladder carcinoma, metastatic thyroid carcinoma, metastatic gastric carcinoma, metastatic bronchogenic carcinoma. How I-Dox 20Mg/10Ml Inj Works I-Dox 20Mg/10Ml Inj contains Doxorubicin, which belongs to the class of anthracycline topoisomerase inhibitors. It inhibits the topoisomerase II enzyme by intercalating the DNA base pairs. This causes double helix DNA to be uncoiled, destroying DNA and RNA synthesis. Storage Store in a cool and dry place away from sunlight Side Effects of I-Dox 20Mg/10Ml Inj Nausea Abdominal pain Vomiting Dizziness Back pain Pain at the site of injection Red discolouration of urine Loss of appetite Mouth sores Tiredness Weight gain What if I have taken an overdose of I-Dox 20Mg/10Ml Inj Since I-Dox 20Mg/10Ml Inj is given in a controlled medical setting by a healthcare professional, an overdose is not likely to occur. If you think there has been an overdose or experiencing any adverse events, get medical care right away. In a medical setting, an overdose would be treated quickly. Overdose of I-Dox 20Mg/10Ml Inj may cause sores in the mouth and throat, fever, sore throat, chills, or other signs of infection, unusual bleeding or bruising, black and tarry stools, red blood in stools, and bloody vomit or vomited material that looks like coffee grounds. Drug Warnings I-Dox 20Mg/10Ml Inj should be avoided if you are allergic to it. It is contraindicated in patients having severe myocardial insufficiency, a recent history of myocardial infarction (MI), severe persistent drug-induced myelosuppression and severe liver disease. Hence avoid using this medicine under such conditions. Inform your doctor if you have any cardiovascular conditions, liver/kidney disease, or taking any CYP3A4 or CYP2D6 inducers medication, as it can cause serious adverse effects. I-Dox 20Mg/10Ml Inj is known to cause embryo-fetal toxicity. Hence it is contraindicated in pregnant or breastfeeding women. Do not stop receiving I-Dox 20Mg/10Ml Inj without a doctor’s advice, as it can cause serious health conditions. I-Dox 20Mg/10Ml Inj is known to cause secondary malignancies.

Erypro safe 10000IU injection contains active components such as Recombinant human erythropoietin alfa/epoetin alfa. It is a medication that belongs to a class of drugs called erythropoiesis-stimulating agents (ESAs). This medication treats anemia caused by chronic kidney disease (CKD), cancer chemotherapy, or HIV infection treatment with zidovudine. It also reduces the need for red blood cell transfusions in patients at high risk for blood loss due to planned surgery or other procedures. Erypro safe 10000IU injection should not be used in patients with hypersensitivity to it or any of its components, uncontrolled hypertension, active thrombotic microangiopathy (TMA), pure red cell aplasia (PRCA), uncontrolled seizures, pregnancy, or lactation. It should also be used cautiously in patients with a history of blood clots, heart disease, stroke, kidney disease, liver disease, thalassemia, sickle cell anemia, myelodysplastic syndrome, leukemia, or cancer. It should only be used in children under 18 if the benefits outweigh the risks. Older adults taking this medication should be closely monitored for side effects. Before starting this medication, it is important to talk to your doctor about the risks and benefits of Erypro safe 10000IU injection.